ClinicalTrials.govpublic full text
Endotype DIrected Treatment for OSA in Down Syndrome
obstructive sleep apnea (osa), down syndrome, obstructive sleep apnea, ato-oxy, precision medicine, oxygen, atomoxetine, oxybutynin, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 845315
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.